ReSound Sensia Now Available To US Veterans Through VA Audiology Clinics
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn your wind-down time into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

GN has made its ReSound Sensia hearing aid line available to U.S. veterans through Department of Veterans Affairs audiology clinics and sites of care nationwide. The portfolio includes rechargeable and battery-powered receiver-in-ear models, custom styles and new bimodal options designed to work with Cochlear Nucleus sound processors.

GN has made its ReSound Sensia hearing aid line available to U.S. veterans through Department of Veterans Affairs audiology clinics and sites of care nationwide, expanding the devices available to VA audiologists for patient fittings. The offering includes several hearing aid styles and new bimodal options designed to work with Cochlear Nucleus sound processors.

ReSound Sensia is built on GN’s new AI platform and launched in the United States in August, according to the source report. Its Intelligent All-Around sound processing is designed to help users focus on a chosen voice in noisy settings. The system combines environmental classification, four-microphone directional beamforming and deep neural network noise reduction to adjust listening support as surroundings change.

The VA portfolio includes rechargeable and battery-powered receiver-in-ear (RIE) models, along with custom-made styles. GN says the line is designed to recognize changing sound environments and activate relevant features automatically, without requiring users to adjust the hearing aids or the ReSound Smart 3D app manually. The source does not provide pricing, eligibility details or information about fitting schedules at individual clinics.

GN also says it is introducing ReSound Sensia Bimodal and ReSound Enzo IA Bimodal, both designed for use with Cochlear Nucleus sound processors. The company presents these as additions to the available fitting options for people using a cochlear implant on one side and a hearing aid on the other. The report describes the products’ intended compatibility but does not provide clinical outcome data or details about how each VA clinic will offer them.

At a glance
announcementWhen: Announced following the U.S. launch of…
The developmentGN announced that ReSound Sensia hearing aids are now available to veterans through VA audiology clinics nationwide.

More Fitting Options at VA Clinics

Making Sensia available through VA audiology sites gives veterans and their clinicians another product line to consider when selecting hearing technology. The range of RIE, rechargeable, battery-powered and custom styles may allow audiologists to match devices to different preferences and fitting needs. Access through VA clinics matters because veterans receive hearing care through a nationwide public health system, though the announcement does not explain whether every site will stock or fit every model.

The automatic sound-processing approach could be relevant to users who prefer fewer manual adjustments, particularly when moving between listening environments. That is a description of the product’s design, not proof that it will improve outcomes for every wearer. Individual benefit can vary, and fitting decisions remain matters for the veteran and their audiology care team.

The bimodal products also extend options for people who use Cochlear Nucleus sound processors. Their availability may help VA audiologists consider a combined hearing aid and cochlear-implant setup within the GN and Cochlear partnership. The announcement does not establish how many veterans will be eligible or how widely the new configurations will be adopted.

As an affiliate, we earn on qualifying purchases.

GN’s Earlier VA Hearing Aid Lines

Sensia’s availability follows earlier introductions of GN hearing aid platforms to VA audiology clinics. The source report says ReSound Vivia and ReSound Nexia had previously been made available to veterans through the VA. The Sensia announcement therefore adds to GN’s existing presence in the VA system rather than marking the company’s first hearing aid offering there.

GN and Cochlear have worked together through the Smart Hearing Alliance, according to the report. The Sensia Bimodal and Enzo IA Bimodal products are described as designed to work with Cochlear Nucleus processors, linking the new VA offering to that collaboration. The report does not specify which Nucleus processor models are supported or whether availability differs by clinic.

GN’s product description emphasizes automated adjustments based on sound environments. The source identifies the technologies involved but does not report independent testing, comparative performance results or veteran-specific research on Sensia. Those distinctions matter when interpreting company statements about features and intended use.

“Veterans often have unique hearing needs, and they deserve the latest technology that helps them join in on the moments that matter most to them without worrying about missing the conversations.”

— Bob Eastman, vice president of ReSound Government Services, in a company release

Clinic Access and Evidence Details

The announcement establishes that Sensia is available through VA audiology clinics and sites of care nationwide, but it does not say when individual clinics will begin fittings, whether all models will be offered at every site or what process veterans should follow to ask about the devices. It also gives no information about costs, coverage rules, eligibility criteria or any changes to existing VA hearing aid services.

Details about the bimodal options are also limited. The report does not identify compatible Nucleus processor models, explain fitting protocols or give data on outcomes for veterans using the products. GN’s descriptions of automatic listening support and voice focus are product claims; the supplied material does not include independent clinical comparisons or quantified results.

Veterans Can Ask VA Audiologists

Veterans interested in ReSound Sensia can ask their VA audiology team whether the line is available at their site and which styles may suit their hearing needs. VA audiologists will determine fitting options through the clinic’s assessment and care process; the announcement does not describe a separate sign-up program or a nationwide fitting timetable.

Further information from GN or the VA could clarify local availability, compatible Cochlear Nucleus models and how the bimodal products will be fitted. Until those details are released, the confirmed development is the portfolio’s stated availability across VA audiology sites, not a guarantee that every model is immediately offered at every clinic.

Key Questions

What is the ReSound Sensia VA announcement?

GN says ReSound Sensia hearing aids are now available to U.S. veterans through VA audiology clinics and sites of care nationwide.

Which Sensia styles are included?

The source report lists rechargeable and battery-powered receiver-in-ear models and custom-made styles. It does not say every clinic will carry each option.

What are the Sensia bimodal options?

GN says ReSound Sensia Bimodal and ReSound Enzo IA Bimodal are designed to work with Cochlear Nucleus sound processors. The report does not specify compatible processor models.

How can a veteran find out whether Sensia is available locally?

Veterans can contact or ask their VA audiology clinic about local availability and fitting options. The announcement does not provide a clinic-by-clinic schedule or a separate enrollment process.

Source: hearingreview.com

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

A hidden immune backup system could supercharge mRNA cancer vaccines

New research uncovers a backup immune mechanism that may enhance the effectiveness of mRNA cancer vaccines, promising improved treatment options.

Scientists may have finally found how Alzheimer’s kills brain cells

New research suggests a specific mechanism behind neuron death in Alzheimer’s, offering potential pathways for treatment. Details are still emerging.

Milestone Pharmaceuticals Surges In Global Coverage

Milestone Pharmaceuticals experiences a surge in international coverage, with 21 mentions in recent media monitoring, signaling increased global interest.

The Science of Self-Discovery: Why It Matters

By exploring the science behind self-discovery, you’ll uncover why understanding your mind is essential for growth and how it can transform your life forever.